Jim Cramer made the following calls on May 22nd, 2013. What do you think about his picks?
Biogen Idec (NASDAQ:BIIB): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on May 14, 2013. The stock’s 52-week high is $217.80, and its 52-week low is $126.39.